Antibody Response to Polysaccharide Conjugate Vaccines after Nonmyeloablative Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 12, 2009, Pages 1523-1530

  Meerveld Eggink, Aafke ^a   van der Velden, Ankie M T ^b   Ossenkoppele, Gert J ^b   van de Loosdrecht, Arjan A ^b   Biesma, Douwe H ^c   Rijkers, Ger T ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Allo RIST; Allogeneic stem cell transplantation; H. influenzae; Pneumococcal; Tetanus toxoid; Vaccination

Indexed keywords

BACTERIUM ANTIBODY; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; FLUDARABINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; LENALIDOMIDE; MENINGOCOCCUS VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; PNEUMOCOCCUS VACCINE; PREDNISOLONE; RITUXIMAB; TETANUS ANTIBODY; THALIDOMIDE; VALACICLOVIR;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIPHTHERIA; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HAEMOPHILUS INFLUENZAE TYPE B; HEMATOLOGIC MALIGNANCY; HUMAN; HUMORAL IMMUNITY; INFECTION; MALE; MENINGOCOCCOSIS; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; REDUCED INTENSITY CONDITIONING; STREPTOCOCCUS PNEUMONIAE; TETANUS; VACCINATION; WHOLE BODY RADIATION;

ADULT; AGED; ANTIBODIES, BACTERIAL; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; STEM CELL TRANSPLANTATION; STREPTOCOCCUS PNEUMONIAE; TETANUS TOXOID; TRANSPLANTATION CONDITIONING; VACCINES, CONJUGATE;

EID: 70350572829     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.07.020     Document Type: Article

References (24)

1. Ljungman P., Engelhard D., de la Cámara R., et al. Vaccination of stem cell transplant recipients: recommendations of the infectious diseases working party of the EBMT. Bone Marrow Transplant 35 (2005) 737-746
2. Vance E., George S., Guinan E.C., et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 22 (1998) 735-741
3. Ljungman P., Wiklund-Hammarsten M., Duraj V., et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 162 (1990) 496-500
4. Center for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 49 (2000) 1-128
5. Siber G.R., Ambrosino D.M., McIver J., et al. Preparation of human hyperimmune globulin to Haemophilus influenza b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun 45 (1984) 248-254
6. Goldblatt D., Levinsky R.J., and Turner M.W. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood. J Infect Dis 166 (1992) 632-634
7. Hermann D.J., Hamilton R.G., Barington T., et al. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide: results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods 148 (1992) 101-114
8. Käyhty H., Peltola H., Karanko V., and Mäkelä P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus Influenzae type b. J Infect Dis 147 (1983) 1100
9. Käythy H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals 22 (1994) 397-402
10. Plotkin S.A. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 20 (2001) 63-75
11. Gottlieb S., McLaughlin F.X., Levine L., et al. Long-term immunity to tetanus-a statistical evaluation and its clinical implications. Am J Public Health Nations Health 54 (1964) 961-971
12. Center for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2006) 55
13. Wernette C.M., Frasch C.E., Madore D., et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 10 (2003) 514-519
14. Skovsted I.C., Kerrn M.B., Sonne-Hansen J., et al. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays. Vaccine 25 (2007) 6490-6500
15. World Health Organization. Pneumococcal conjugate vaccines. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Tech Rep Ser 927 annex 2 (2005) 64-98
16. Savage W.J., Bleesing J.J.H., Douek D., et al. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows 2 patterns depending on age and donor/recipient chimerism. Bone Marrow Transplant 28 (2001) 463-471
17. Morecki S., Gelfand Y., Nagler A., et al. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. Bone Marrow Transplant 28 (2001) 243-249
18. Maris M., Boeckh M., Storer B., et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol 31 (2003) 941-952
19. van der Velden A.M.T., Claessen A.M., van Velzen-Blad H., et al. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. Vaccine 25 (2007) 8512-8517
20. Molrine D.C., Guinan E.C., Antin J.H., et al. Donor immunization with Haemophilus influenzae type B (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 87 (1996) 3012-3018
21. Parkkali T., Ölander R.-M., Ruutu T., et al. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant 19 (1997) 933-938
22. Molrine D.C., Antin J.H., Guinan E.C., et al. Donor immunizaton with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 101 (2003) 831-836
23. Storek J., Viganego F., Dawson M.A., et al. Factors affecting antibody levels after allogeneic hematopoietic cell transplantation. Blood 101 (2003) 3319-3324
24. Cordonnier C., Labopin M., Chesnel V., et al. Immune response to the 23-valent polysaccharide pneumococcal vaccine (PPV23) after the 7-valent conjugate vaccine (PCV7) in allogeneic stem cell transplant (SCT) recipients: results of the EBMT IDWP01 Trial. Blood ASH Annu Meet Abstr 112 (2008) Abstract 350